PyInvesting

Market research

1312.HK Tongfang Kontafarma Holdings Limited

HK HKD Healthcare

Latest close

0.03 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
151M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
0.11

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Tongfang Kontafarma Holdings Limited is currently in a long term uptrend where the price is trading 5.8% above its 200 day moving average.

From a valuation standpoint, the stock is 85.7% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.2.

Tongfang Kontafarma Holdings Limited's total revenue rose by 301.5% to $711M since the same quarter in the previous year.

Its net income has dropped by 180.0% to $-49M since the same quarter in the previous year.

Finally, its free cash flow grew by 209.0% to $80M since the same quarter in the previous year.

Based on the above factors, Tongfang Kontafarma Holdings Limited gets an overall score of 4/5.